| RS1559110846 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1559114055 |
PNPT1
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 13, Combined oxidative phosphorylation defect type 13 |
| RS1559114202 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1559114303 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS1559114408 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS1559114837 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Developmental and epileptic encephalopathy |
| RS1559118914 |
SCN1A
|
Health Risk |
Likely pathogenic |
Autosomal dominant epilepsy, Autosomal dominant epilepsy |
| RS1559118996 |
SCN1A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1559119345 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Inborn genetic diseases |
| RS1559120651 |
ABCA12
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 4B, Autosomal recessive congenital ichthyosis 4B |
| RS1559121920 |
BBS5
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1559122124 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe myoclonic epilepsy in infancy, Acute encephalopathy |
| RS1559122157 |
BBS5
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 5, Bardet-Biedl syndrome |
| RS1559122263 |
SCN1A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1559122277 |
BBS5
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 5, Bardet-Biedl syndrome 5 |
| RS1559126736 |
BBS5
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 5, Bardet-Biedl syndrome 5 |
| RS1559127505 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-infantile DEE, Epilepsy |
| RS1559128483 |
SCN1A
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS1559128532 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1559129372 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS1559130635 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS1559134341 |
ABCA12
|
Health Risk |
Likely pathogenic |
Autosomal recessive congenital ichthyosis 4B, Autosomal recessive congenital ichthyosis 4B |
| RS1559136030 |
SATB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS1559136245 |
SATB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS1559138079 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1559138455 |
SMARCAL1
|
Health Risk |
Likely pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS1559138957 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS1559140110 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1559140155 |
SCN1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 6B, Developmental and epileptic encephalopathy 6B |
| RS1559140306 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1559140855 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1559141367 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1559142152 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1559144583 |
SCN1A
|
Health Risk |
Pathogenic |
Primary generalized epilepsy, Early-infantile DEE |
| RS1559144956 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1559147521 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1559149128 |
SCN1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, Severe myoclonic epilepsy in infancy |
| RS1559151333 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1559155162 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1559155954 |
OBSL1
|
Health Risk |
Pathogenic/Likely pathogenic |
3M syndrome 1, 3M syndrome 2 |
| RS1559159868 |
ITGA6
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa with pyloric atresia, Epidermolysis bullosa |
| RS1559160379 |
OBSL1
|
Health Risk |
Pathogenic |
3M syndrome 2, 3M syndrome 2 |
| RS1559162681 |
DYSF
|
Health Risk |
Pathogenic |
— |
| RS1559164234 |
SATB2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1559168230 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy, Nemaline myopathy 2 |
| RS1559173391 |
TTN
|
Health Risk |
Likely pathogenic |
Congenital titinopathy, Early-onset myopathy with fatal cardiomyopathy |
| RS1559175090 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1559175170 |
SATB2
|
Health Risk |
Pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS1559177278 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS1559183490 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS1559183717 |
ABCB11
|
Health Risk |
Pathogenic/Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS1559184972 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS1559186257 |
DYSF
|
Health Risk |
Pathogenic |
DYSF-related disorder, Autosomal recessive limb-girdle muscular dystrophy |
| RS1559187287 |
TTN
|
Health Risk |
Likely pathogenic |
Myopathy, myofibrillar |
| RS1559190144 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1559192617 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS1559193050 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1559193213 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1559195296 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1559199628 |
SCN1A
|
Health Risk |
Likely pathogenic |
Lung cancer, Early-infantile DEE |
| RS1559200525 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1559200672 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1559200901 |
SCN1A
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Developmental and epileptic encephalopathy 6B |
| RS1559200975 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1559207733 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1559210063 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1559216207 |
DIS3L2
|
Health Risk |
Pathogenic |
Perlman syndrome, Perlman syndrome |
| RS1559216338 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1559216544 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1559217202 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1559217391 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1559218052 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1559218619 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1559220022 |
DIS3L2
|
Health Risk |
Pathogenic/Likely pathogenic |
Perlman syndrome, Perlman syndrome |
| RS1559220874 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1559221602 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1559221910 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1559225495 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1559225974 |
COL6A3
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1559225993 |
COL6A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Ullrich congenital muscular dystrophy 1A |
| RS1559228507 |
COL6A3
|
Health Risk |
Pathogenic |
— |
| RS1559229322 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1559231280 |
TRNT1
|
Health Risk |
Pathogenic |
Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome, Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome |
| RS1559231284 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1559234260 |
COL6A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1559237625 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS1559238215 |
SCN1A
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS1559238432 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1559245286 |
DCAF17
|
Health Risk |
Pathogenic |
Woodhouse-Sakati syndrome, Woodhouse-Sakati syndrome |
| RS1559245847 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS1559247315 |
SLC19A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Biotin-responsive basal ganglia disease, Biotin-responsive basal ganglia disease |
| RS1559249734 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1559250774 |
SLC19A3
|
Health Risk |
Pathogenic |
Biotin-responsive basal ganglia disease, Biotin-responsive basal ganglia disease |
| RS1559252723 |
SLC19A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Biotin-responsive basal ganglia disease, Biotin-responsive basal ganglia disease |
| RS1559253935 |
COL6A3
|
Health Risk |
Pathogenic |
— |
| RS1559255553 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1559257971 |
COL6A3
|
Health Risk |
Pathogenic |
— |
| RS1559261557 |
COL6A3
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1559262463 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS1559264135 |
DCAF17
|
Health Risk |
Pathogenic |
Woodhouse-Sakati syndrome, Woodhouse-Sakati syndrome |